- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Oxford BioMedica PLC (OXB)
Oxford BioMedica PLC stock price live, this page displays LON OXB stock exchange data. View the OXB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Oxford BioMedica PLC real time stock price chart below.
What Is the Oxford BioMedica PLC Stock Price Today?
The Oxford BioMedica PLC stock price today is 430.00.
What Is the Stock Symbol for Oxford BioMedica PLC?
The stock symbol for Oxford BioMedica PLC is ""OXB.""
What Stock Exchange Does Oxford BioMedica PLC Trade On?
Oxford BioMedica PLC is listed and trades on the London stock exchange.
Is Oxford BioMedica PLC a Good Stock to Buy?
Determining whether Oxford BioMedica PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OXB quote. (ISIN: GB00BDFBVT43)
What Is the Oxford BioMedica PLC Stock Price Today?
The Oxford BioMedica PLC stock price today is 430.00.
What Is the Stock Symbol for Oxford BioMedica PLC?
The stock symbol for Oxford BioMedica PLC is ""OXB.""
What Stock Exchange Does Oxford BioMedica PLC Trade On?
Oxford BioMedica PLC is listed and trades on the London stock exchange.
Is Oxford BioMedica PLC a Good Stock to Buy?
Determining whether Oxford BioMedica PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OXB quote. (ISIN: GB00BDFBVT43)
London
Currency in GBP
430.00
0.00(0.00%)
Real-time Data·
Fair Value
An estimate of a Oxford BioMedica's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
430.00
430.30
52 wk Range
4.11
470.50
OXB Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
OXB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Oxford BioMedica's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
430.00430.30
52 wk Range
4.11470.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
OXB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Oxford BioMedica's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
507.75
Upside
+18.08%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Oxford Biomedica receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Oxford Biomedica receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Oxford Biomedica receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Oxford BioMedica PLC Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.
Compare OXB to Peers and Sector
Metrics to compare | OXB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOXBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.8x | −5.9x | −0.5x | |
PEG Ratio | −0.14 | −0.06 | 0.00 | |
Price/Book | 8.2x | 4.4x | 2.6x | |
Price / LTM Sales | 3.6x | 12.3x | 3.3x | |
Upside (Analyst Target) | 11.6% | 87.7% | 42.9% | |
Fair Value Upside | Unlock | 3.0% | 6.2% | Unlock |
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 507.75
(+18.08% Upside)
Earnings
Latest Release
Apr 25, 2025
EPS / Forecast
-0.11 / -0.0784
Revenue / Forecast
77.99M / 77.20M
People Also Watch
FAQ
What Stock Exchange Does Oxford BioMedica Trade On?
Oxford BioMedica is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Oxford BioMedica?
The stock symbol for Oxford BioMedica is "OXB."
What Is the Oxford BioMedica Market Cap?
As of today, Oxford BioMedica market cap is 456.66M.
What Is Oxford BioMedica's Earnings Per Share (TTM)?
The Oxford BioMedica EPS (TTM) is -0.42.
When Is the Next Oxford BioMedica Earnings Date?
Oxford BioMedica will release its next earnings report on 22 Sept 2025.
From a Technical Analysis Perspective, Is OXB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Oxford BioMedica Stock Split?
Oxford BioMedica has split 7 times.
How Many Employees Does Oxford BioMedica Have?
Oxford BioMedica has 850 employees.
What is the current trading status of Oxford BioMedica (OXB)?
As of 12 Aug 2025, Oxford BioMedica (OXB) is trading at a price of 430.00, with a previous close of 430.00. The stock has fluctuated within a day range of 430.00 to 430.30, while its 52-week range spans from 4.11 to 470.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.